PMNS20190727, Exubrion Therapeutics, Inc Public Meeting

Exubrion Therapeutics, Inc Public Meeting

ML19207A501
Person / Time
Issue date:	07/26/2019
From:	Office of Nuclear Material Safety and Safeguards
To:
References
PMNS20190727
Download: ML19207A501 (2)

Text

Title:

Exubrion Therapeutics, Inc Public Meeting Date(s) and Time(s): July 29, 2019, 01:00 PM to 03:00 PM Location: NRC One White Flint North, 12B4 11555 Rockville Pike Rockville, MD Category: This is a Open meeting. Public participation is actively sought for this meeting to fully engage the public in a discussion of regulatory issues.

Purpose:

For Exubrion Therapeutics, Inc to discuss its veterinary uses of Sn-117

Contact:

Donna-Beth Howe 301-415-5441 donna-beth.howe@nrc.gov

Participants:

NRC Office of Nuclear Material Safety and Safeguards Bridge Number Pass Code Teleconference:

(188) 846-9205 9916706

PUBLIC MEETING AGENDA

Exubrion Therapeutics, Inc Public Meeting July 29, 2019, 01:00 PM to 03:00 PM NRC One White Flint North, 12B4 11555 Rockville Pike Rockville, MD

The time of the meeting is local to the jurisdiction where the meeting is being held.

The NRC provides reasonable accommodation to individuals with disabilities where appropriate. If reasonable accommodation is needed to participate in this meeting, or if a meeting notice, transcript, or other information from this meeting is needed in another format (e.g., Braille, large print), please notify the NRC meeting contact.

Determinations on requests for reasonable accommodation will be made on a case-by-case basis.

ADAMS Accession Number: ML19207A501 OFFICIAL RECORD COPY Link to meeting details: https://www.nrc.gov/pmns/mtg?do=details&Code=20190727 Commission's Policy Statement on "Enhancing Public Participation in NRC Meetings" 67 Federal Register 36920, May 28, 2002 The policy statement may be found on the NRC website http://www.nrc.gov/reading-rm/doc-collections/commission/policy/67fr36920.html